超声弹性成像与血清纤维化指标评估Wilson病肝脏受累的诊断效能
回顾性纳入45例Wilson病患者,比较瞬时弹性成像(TE)、二维剪切波弹性成像(2D SWE)、APRI及FIB-4评分区分肝脏受累临床分级(I-V)的诊断效能。TE、2D SWE与APRI区分各临床分级的AUROC为0.799-0.928,FIB-4区分I级与其他级别的AUROC为0.647。血清标志物联合超声弹性成像可显著提高FIB-4的AUROC(联合TE P=.01,联合2D SWE P=.02)。
要点
- TE与2D SWE区分Wilson病肝脏受累临床分级(I-V)的AUROC为0.799-0.928。
- APRI区分各临床分级的诊断效能优于FIB-4(后者AUROC 0.647)。
- 血清标志物联合超声弹性成像可提高FIB-4的AUROC(联合TE P=.01,联合2D SWE P=.02)。
核心结论
- TE和2D SWE区分Wilson病肝脏受累临床分级具有很高的诊断准确度。
- APRI的诊断效能优于FIB-4评分。
- 超声弹性成像联合血清学指标可改善对Wilson病肝脏表现的评估。
研究设计与样本
- 回顾性研究,纳入确诊Wilson病且同日接受TE和2D SWE检查的患者45例(中位年龄16.0岁,范围3-35岁)。
- 根据实验室检查、超声肝脏形态学特征及肝硬化临床症状将肝脏受累分为5个临床类别:I正常(n=17)、II仅生化异常(n=15)、III肝脏形态学改变(n=10)、IV代偿期肝硬化(n=3)、V失代偿期肝硬化(n=0)。
- 计算APRI和FIB-4评分,比较TE、2D SWE、APRI及FIB-4的AUROC,并评估血清标志物与超声弹性成像联合后的AUROC。
诊断标准与关键数值
- TE、2D SWE和APRI区分临床类别的AUROC为0.799-0.928。
- FIB-4区分临床类别I与其他类别的AUROC为0.647。
- FIB-4联合TE后AUROC较单用FIB-4显著提高(P=.01)。
- FIB-4联合2D SWE后AUROC较单用FIB-4显著提高(P=.02)。
临床应用与阅片要点
- 阅片时可结合TE或2D SWE测值及APRI辅助区分Wilson病肝脏受累的临床分级。
- FIB-4单独用于区分临床类别I与其他类别时诊断价值较低(AUROC 0.647)。
- 将超声弹性成像与血清学指标联合评估,可提高FIB-4对Wilson病肝脏表现的评估效能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the diagnostic value of transient elastography (TE), 2-dimensional (2D) shear wave elastography (SWE), and the serologic fibrosis indices aspartate transaminase-to-platelet ratio index (APRI) and Fibrosis-4 (FIB-4) score for Wilson disease (WD).
METHODS: We retrospectively identified patients with a diagnosis of WD who underwent TE and 2D SWE on the same day. Their APRI and FIB-4 scores were calculated. Hepatic involvement was classified into 5 clinical categories (I-V) based on the laboratory findings, hepatic morphologic characteristics on ultrasound (US) imaging, and clinical symptoms of cirrhosis: I, normal (n = 17); II, only biochemical abnormality (n = 15); III, altered hepatic morphologic characteristics (n = 10); IV, compensated liver cirrhosis (n = 3); and V, decompensated liver cirrhosis (n = 0). We compared the area under the receiver operating characteristic curve (AUROC) data for TE, 2D SWE, the APRI, and the FIB-4 score. A combined assessment of the serologic markers and US elastography was performed, and the AUROCs of the combinations were compared.
RESULTS: Forty-five patients were included in the study (median age, 16.0 years; range, 3-35 years). Transient elastography, 2D SWE, and APRI were comparable in distinguishing the clinical categories (AUROC, 0.799-0.928). The FIB-4 score showed lower diagnostic value in distinguishing clinical category I from the other categories (AUROC, 0.647). Combining the serologic markers and US elastography significantly increased the AUROC value of the FIB-4 score (with TE and 2D SWE, P = .01 and .02).
CONCLUSIONS: Transient elastography and 2D SWE showed excellent diagnostic accuracy for differentiating the clinical categories of hepatic involvement. The APRI showed better diagnostic performance than the FIB-4 score. The assessment of hepatic manifestations in WD can be improved by combining US elastography with serologic indices.
引用
- Hwang J, Yoon HM, Jung AY, et al. Diagnostic Performance of Ultrasound Elastography and Serologic Fibrosis Indices for Evaluation of Hepatic Involvement in Wilson Disease. J Ultrasound Med. 2020. PMID: 32401363. doi:10.1002/jum.15334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。